A metabonomic approach to the investigation of drug-induced phospholipidosis: An NMR spectroscopy and pattern recognition study

Biomarkers

Volumn 5, Issue 6, 2000, Pages 410-423

  Nicholls, A W ^a   Nicholson, J K ^a   Haselden, J N ^a   Waterfield, C J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

1H NMR; Cationic amphiphilics; Metabonomics; Phenylacetate; Phenylacetylglycine; Phospholipidosis; Urinalysis

Indexed keywords

2 OXOGLUTARIC ACID; AMIODARONE; CHLOROQUINE; CHLORPROMAZINE; CITRIC ACID; GLYCINE; LIPID;

ANIMAL EXPERIMENT; ARTICLE; DRUG SCREENING; ELECTRON MICROSCOPY; LIPIDOSIS; LIVER TOXICITY; LUNG ALVEOLUS MACROPHAGE; LUNG TOXICITY; NEPHROTOXICITY; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

EID: 0034530607     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475000750052420     Document Type: Article

References (35)

1. Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: Proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage
2. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins
3. Drugs affecting the synthesis of glycerides and phospholipids in rat liver. The effects of clofibrate, halofenate, fenfluramine, amphetamine, cinchocaine, chloropromazine, demethylimipramine, mepyramine and some of their derivatives
4. Plasma concentrations of p- and m-hydroxyphenylacetic acid and phenylacetic acid in humans. Gas chromatographic-high resolution mass spectrometric analysis
5. Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behaviour and mood rating scores in brofaromine-treated woman with bulimia nervosa
6. New tables for multiple comparisons with a control
7. Lysosomotropic agents
8. Gut flora and the origin of some urinary aromatic phenolic compounds
9. Creatinuria as an early indicator of cadmium induced testicular damage
10. Studies on the relationship between testicular toxicity and urinary and plasma creatine concentration
11. Cationic amphiphilic drug-induced phospholipidosis
12. Drug-induced lung toxicity
13. Proton NMR monitoring of the onset and recovery of experimental renal damage
14. 1H NMR spectroscopy of urine combined with pattern-recognition
15. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine
16. Drug-induced lung toxicity
17. Alveolar proteinosis and phospholipidoses of the lungs
18. Some observations on the urinary excretions of glycine conjugates by laboratory animals
19. Phenylacetic acid excretion in schizophrenia and depression: The origins of PAA in man
20. Cationic amphiphilic drugs and phospholipid storage disorder
21. In Vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats
22. NMR spectroscopy of biofluids
23. Drug induced phospholipidosis
24. High-resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development
25. High resolution proton magnetic resonance spectroscopy of biofluids
26. 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat
27. 13C-NMR spectroscopy of human blood plasma
28. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data
29. Amioadrone-induced phospholipidosis in rat alveolar macrophages
30. Urinary phenylacetate: A diagnostic test for depression?
31. Hepatotoxin-induced hypertaurinuria: A proton NMR study
32. Investigations into the effects of various hepatotoxic compounds on urinary and liver levels of taurine in rats
33. Effects of various non-hepatotoxic compounds on urinary and liver levels of taurine in rats